Ardelyx Inc. News
Ardelyx Plunges as FDA Questions Kidney Disorder Treatment Drug
Ardelyx shares plunge after the Food and Drug Administration identifies 'deficiencies' on the company’s application for its kidney disease fighting drug Tenapanor.
5 Top Stock Gainers for Thursday: Weingarten Realty, Dell, Nvidia
Weingarten Realty, Dell, Nvidia, GlaxoSmithKline and Ardelyx are five top stock gainers for Thursday.
Biotech premarket movers: Ardelyx, Acorda Therapeutics, Medicines Co.
Ardelyx, Acorda Therapeutics and Medicines Co. were among the premarket biotech movers on Wednesday.
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa.
These 5 under-$10 biotech stocks are about to break out
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Insider Trading Alert - ARDX, CARA And ALXN Traded By Insiders
Stocks with insider trader activity include ARDX, CARA and ALXN
Dr. Doom Sees Plenty of Gloom: Roubini's Bearish Musings
He predicts a global economic and financial crisis, sparked by a debt bubble and accompanied by stagflation.